AU2003263480A1 - Oral pharmaceutical compositions of fenofibrate having high bioavailability - Google Patents

Oral pharmaceutical compositions of fenofibrate having high bioavailability

Info

Publication number: AU2003263480A1
Authority: AU; Australia
Prior art keywords: fenofibrate; pharmaceutical compositions; oral pharmaceutical; high bioavailability; bioavailability
Prior art date: 2002-09-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003263480A

Other versions

AU2003263480A8 (en

Inventor

Rajiv Malik

Gowri Shankar Miriyala

Ajay Kumar Singla

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ranbaxy Laboratories Ltd

Original Assignee

Ranbaxy Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-24

Filing date

2003-09-24

Publication date

2004-04-19

2003-09-24 Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd

2004-04-19 Publication of AU2003263480A8 publication Critical patent/AU2003263480A8/en

2004-04-19 Publication of AU2003263480A1 publication Critical patent/AU2003263480A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)

AU2003263480A 2002-09-24 2003-09-24 Oral pharmaceutical compositions of fenofibrate having high bioavailability Abandoned AU2003263480A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN961DE2002		2002-09-24
IN961/DEL/2002		2002-09-24
PCT/IB2003/004162 WO2004028506A1 (en)	2002-09-24	2003-09-24	Oral pharmaceutical compositions of fenofibrate having high bioavailability

Publications (2)

Publication Number	Publication Date
AU2003263480A8 AU2003263480A8 (en)	2004-04-19
AU2003263480A1 true AU2003263480A1 (en)	2004-04-19

Family

ID=32040231

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003263480A Abandoned AU2003263480A1 (en)	2002-09-24	2003-09-24	Oral pharmaceutical compositions of fenofibrate having high bioavailability

Country Status (3)

Country	Link
EP (1)	EP1553928A1 (en)
AU (1)	AU2003263480A1 (en)
WO (1)	WO2004028506A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006060817A1 (en) *	2004-12-03	2006-06-08	Abbott Laboratories	Pharmaceutical compositions
WO2008075320A2 (en) *	2006-12-21	2008-06-26	Ranbaxy Laboratories Limited	Antilipidemic pharmaceutical compositions and process for preparation thereof
US20110097414A1 (en) *	2007-02-26	2011-04-28	Sandal Roshan Lal	Pharmaceutical compositions comprising adsorbate of fenofibrate
EP2842547A1 (en)	2013-08-27	2015-03-04	Freund Pharmatec Ltd.	Improved fenofibrate compositions
EP2878311A1 (en)	2013-11-27	2015-06-03	Freund Pharmatec Ltd.	Solubility Enhancement for Hydrophobic Drugs
CN109481437B (en) *	2017-09-13	2020-12-18	北京福元医药股份有限公司	Losartan potassium pharmaceutical preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2494112B1 (en) *	1980-11-19	1986-01-10	Laruelle Claude
FR2758459B1 (en) *	1997-01-17	1999-05-07	Pharma Pass	FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
FR2783421B1 (en) *	1998-09-17	2000-11-24	Cll Pharma	PROCESS FOR THE PREPARATION OF NOVEL GALENIC FORMULATIONS OF FENOFIBRATE, GALENIC FORMULATIONS OBTAINED BY SAID PROCESS AND THEIR APPLICATIONS
FR2795961B1 (en) *	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	PHARMACEUTICAL COMPOSITION CONTAINING MICRONIZED FENOFIBRATE, A SURFACTANT AND A BINDING CELLULOSIC DERIVATIVE AND PREPARATION METHOD
US6531158B1 (en) *	2000-08-09	2003-03-11	Impax Laboratories, Inc.	Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
FR2819720B1 (en) *	2001-01-22	2004-03-12	Fournier Lab Sa	NEW FENOFIBRATE TABLETS
KR20040098023A (en) *	2002-03-26	2004-11-18	테바 파마슈티컬 인더스트리즈 리미티드	Drug microparticles

2003
- 2003-09-24 WO PCT/IB2003/004162 patent/WO2004028506A1/en not_active Ceased
- 2003-09-24 AU AU2003263480A patent/AU2003263480A1/en not_active Abandoned
- 2003-09-24 EP EP03798327A patent/EP1553928A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO2004028506A1 (en)	2004-04-08
AU2003263480A8 (en)	2004-04-19
EP1553928A1 (en)	2005-07-20

Similar Documents

Publication	Publication Date	Title
AU2003296897A1 (en)	2004-05-04	Pharmaceutical formulations of camptothecine derivatives
PL375833A1 (en)	2005-12-12	Pharmaceutical formulations of modafinil
IL162118A0 (en)	2005-11-20	Pharmaceutical compositions containing an orally active taxane derivative
AU2003298841A1 (en)	2004-06-30	Pharmaceutical compositions containing indistinguishable drug components
AU2003291103A1 (en)	2004-06-15	Pharmaceutical composition
AU2003245504A1 (en)	2003-12-31	Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2003246978A1 (en)	2004-02-23	Pharmaceutical compositions comprising cyclosporin for oral administration
AU2003226189A1 (en)	2003-10-20	Oral administration of epothilones
AU2003250372A1 (en)	2004-01-06	Pharmaceutical composition
AU2003276572A1 (en)	2004-06-15	Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2003249105A1 (en)	2004-01-23	Processes for the preparation of oral dosage formulations of modafinil
AU2003201071A1 (en)	2003-07-30	Stable pharmaceutical compositions comprising ace inhibitor(s)
AU2003276688A1 (en)	2004-03-19	Pharmaceutical composition of metaxalone with enhanced oral bioavailability
GB0202900D0 (en)	2002-03-27	Novel formulations of drugs
PL375831A1 (en)	2005-12-12	Novel pharmaceutical formulations of modafinil
AU2003263480A1 (en)	2004-04-19	Oral pharmaceutical compositions of fenofibrate having high bioavailability
AU2003297927A1 (en)	2004-06-30	Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
AU2003279392A1 (en)	2004-01-06	Pharmaceutical compositions of azithromycin
AU2003216503A1 (en)	2003-09-22	Stable pharmaceutical compositions
AU2003295846A1 (en)	2004-06-18	Pharmaceutical formulations of celcoxib
AU2003274410A1 (en)	2004-05-13	Pharmaceutical compositions of ganciclovir
AU2003284786A1 (en)	2004-06-23	Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
AU2003251643A1 (en)	2004-02-23	Pharmaceutical compositions containing keto-acids for endoperitoneal administration
AU2003247001A1 (en)	2004-02-16	Processes for the preparation of oral dosage formulations of modafinil
AU2002339720A1 (en)	2004-01-06	Improved pharmaceutical dental formulations

Legal Events

Date	Code	Title	Description
2005-06-09	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase